NPPA issues notices for overcharging to Pharma firms

Published On 2016-04-27 05:52 GMT   |   Update On 2016-04-27 05:52 GMT

New Delhi : The National Pharmaceutical Pricing Authority (NPPA) has issued notices, during 2015-16, to 263 pharma firms, which were found overcharging for their products,parliament was told on Tuesday.


The NPPA issued demand notices to 263 companies amounting to Rs.928.32 crore during the last fiscal, and recoveries effected are to the tune of Rs.12.68 crore, Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir told the Lok Sabha in a written reply.


"Whenever companies are found overcharging the consumer in respect to price of medicines, NPPA issues demand notices for recovery of overcharged amount along with interest thereon under various provisions of DPCO (Drugs Price Contrl Order) 1995 and DPCO 2013," he said.


"The ceiling price of scheduled medicines are fixed by NPPA on market-based methodology. The companies are not allowed to increase the price beyond wholesale price index in a year," he added.


 
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News